GLP-1 agonists are a class of injectable medications that are used for type 2 diabetes and weight management. Some of the agents have also been shown to reduce the risk of major adverse cardiovascular events such as cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. More recently, these agents have gained popularity in assisting in weight loss. If you missed a dose of GLP-1 medication and are unsure of what to do, see below the guidance for each GLP-1 medication available.

If you have additional questions about injectable GLP-1 agonist medications or what to do if you missed a dose of GLP-1 medication, you could always chat with a pharmacist online 24/7.

Missed a Dose of GLP-1 Medication: By Medication

Missed a dose of GLP-1 medication Mounjaro (tirzepatide):

Missed a dose of GLP-1 medication Mounjaro

Available Strengths: 2.5mg, 5mg, 7.5mg 10mg, 12.5mg, 15mg
Who manufactures Mounjaro? Eli Lilly
Missed a dose of Mounjaro (tirzepatide)? For any strength: Dose should be administered as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule. Keep in mind that the weekly administration day can be changed as long as the time between doses is a least 3 days (72 hours).

Missed a dose of GLP-1 medication Ozempic (semaglutide):

Missed a Dose of GLP-1 Medication Ozempic

Available Strengths: 0.25mg, 0.5mg, 1mg, 2mg
Who manufactures Ozempic? Novo Nordisk
Missed a dose of Ozempic (semaglutide)? For any strength: Dose should be administered as soon as possible within 5 days (120 hours) after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule. Keep in mind that the weekly administration day can be changed as long as the time between doses is a least 2 days (48 hours).

Missed a dose of GLP-1 medication Trulicity (dulaglutide):

Missed a Dose of GLP-1 Medication Trulicity

Available Strengths: 0.75mg, 1.5mg, 3mg, 4.5mg
Who manufactures Trulicity? Eli Lilly
Missed a dose of Trulicity (dulaglutide)? For any strength: Dose should be administered as soon as possible within 3 days (72 hours) after the missed dose. If more than 3 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule. Keep in mind that the weekly administration day can be changed as long as the time between doses is a least 3 days (72 hours).

Missed a dose of GLP-1 medication Victoza (liraglutide):

Missed a Dose of GLP-1 Medication Victoza

Available Strengths: 0.6mg, 1.2mg, 1.8mg
Who manufactures Victoza (liraglutide)? Novo Nordisk
Missed a dose of Victoza (liraglutide)? For any strength: Instruct patients who miss a dose of liraglutide injection to resume the once daily dosage regimen as prescribed with the next scheduled dose. Do not administer an extra dose or increase the dose to make up for the missed dose.

Ask A Pharmacist Online About GLP-1 Medications

Want additional live support with your injectable GLP-1 agonist medication questions? Ask a pharmacist online 24/7.

References

  1. DailyMed – MOUNJARO- tirzepatide injection, solution. Accessed March 31, 2025. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  2. DailyMed – OZEMPIC- semaglutide injection, solution. Accessed March 31, 2025. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  3. DailyMed – TRULICITY- dulaglutide injection, solution. Accessed April 1, 2025. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309
  4. DailyMed – LIRAGLUTIDE injection. Accessed April 1, 2025. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2100ec49-57b2-4330-ab5f-057ce9b7e4d0


Disclaimer: This website does not provide medical advice. No content on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. All content on this site is for educational and informational purposes only, does not constitute medical advice, and does not establish any kind of patient-provider or client-professional relationship by your use of this website. Although we strive to strictly provide accurate and up to date general information, content available on this site is not a substitute for professional medical advice, and you should not rely solely on the information provided here. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding medical conditions, treatments, or medications.



author avatar
Matthew Bridges, PharmD, BCEMP, BCPS
Matt Bridges grew up in Illinois and now lives and works in Florida as an ER Clinical Pharmacist. He is a passionate and versatile pharmacist with many years of hospital pharmacy experience. He graduated from Butler University College of Pharmacy and Health Sciences and has since completed a post-graduate year in an ASHP-accredited pharmacy residency program. Matt is also dual board-certified in Emergency Medicine (BCEMP) and Pharmacotherapy (BCPS). Outside of pharmacy, he loves all sports and will always be a lifelong Butler Bulldogs basketball fan and Green Bay Packers fan. In his free time, Matt enjoys traveling to new countries, hiking national parks, fishing, and growing his relationships with friends and family.